Stephens & Co. Initiates Coverage On IDEAYA Biosciences With Overweight Rating, Announces Price Target of $51
Stephens & Co. Initiates Coverage On IDEAYA Biosciences With Overweight Rating, Announces Price Target of $51
Stephens公司啓動對ideaya生物科學的股票覆蓋，評級爲超配，宣佈目標股價爲51美元
Stephens & Co. analyst Sudan Loganathan initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight rating and announces Price Target of $51.
Stephens公司分析師Sudan Loganathan啓動對ideaya生物科學（納斯達克:IDYA）的股票覆蓋，並給予超配評級，宣佈目標股價爲51美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。